Patents/Inventors

Ralf Hosse

SchlierenCH21 patents

14 Patents

US126007812026
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US124733732025
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites
US122864862025
Anti-fap Antibodies and Methods of Use
Roche Glycart AG
0 cites
US122409112025
Bispecific Antibodies Specific for OX40
Hoffmann-la Roche Inc.
0 cites
US122151552025
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US121395532024
T Cell Activating Bispecific Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US121039822024
T Cell Activating Bispecific Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US119524212024
Bispecific Antibodies Against CD3EPSILON and ROR1
Bristol-myers Squibb Company
0 cites
US118277112023
Antibodies Binding to NKG2D
Hoffmann-la Roche Inc.
0 cites
US117878732023
Bispecific HER2 Antibodies and Methods of Use
Hoffmann-la Roche Inc.
0 cites
US117809202023
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US116728582023
Bispecific Antibody Molecules Binding to CD3 and TYRP-1
Hoffmann-la Roche Inc.
0 cites
US116083762023
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US115913972023
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites